U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
173611173611Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery DeviceWithdrawnNo Results AvailableGlaucoma, Open-Angle|Ocular HypertensionDrug: Xalatanhttps://ClinicalTrials.gov/show/NCT00283764
173612173612Comparison of Insulin Detemir or Insulin Glargine as Add on to Oral Antidiabetic Drugs in Type 2 DiabetesCompletedNo Results AvailableDiabetes|Diabetes Mellitus, Type 2Drug: insulin detemir|Drug: insulin glarginehttps://ClinicalTrials.gov/show/NCT00283751
173613173613MIST II PFO-Migraine Trial With BioSTAR® Bioabsorbable Septal Repair ImplantActive, not recruitingNo Results AvailableMigraine|Aura|Patent Foramen OvaleDevice: BioSTAR Septal Repair Implant System|Procedure: Sham Procedurehttps://ClinicalTrials.gov/show/NCT00283738
173614173614Use of Different Treatment Care Methods in Patients With Dementia Associated With Alzheimer's DiseaseCompletedNo Results AvailableDementia|Alzheimer's DiseaseOther: No interventionhttps://ClinicalTrials.gov/show/NCT00283725
173615173615Use of Infliximab for the Treatment of Pemphigus VulgarisCompletedHas ResultsPemphigusDrug: Infliximab|Drug: Prednisone|Other: Placebohttps://ClinicalTrials.gov/show/NCT00283712
173616173616A Pilot Study of Neurocysticercosis TreatmentCompletedNo Results AvailableNeurocysticercosisDrug: albendazole|Other: placebohttps://ClinicalTrials.gov/show/NCT00283699
173617173617HALT Progression of Polycystic Kidney Disease (HALT PKD) Study ACompletedHas ResultsKidney, PolycysticDrug: Lisinopril|Drug: Telmisartan|Drug: Placebo|Other: Standard Blood Pressure Control|Other: Low Blood Pressure Controlhttps://ClinicalTrials.gov/show/NCT00283686
173618173618Effect of Exercise Intervention on Various Physiologic Factors That Change With Increasing AgeCompletedNo Results AvailableAgingBehavioral: Exercisehttps://ClinicalTrials.gov/show/NCT00283673
173619173619Zinc, Mental Health, and School Performance in Guatemalan SchoolchildrenCompletedNo Results AvailableDepression|AnxietyDietary Supplement: 10 mg zinc oxidehttps://ClinicalTrials.gov/show/NCT00283660
173620173620MR Assessment of Brain Function Altered by Lead ExposureCompletedNo Results AvailableLead Exposurehttps://ClinicalTrials.gov/show/NCT00283647
173621173621A Study of Tarceva for Use in Patients With Relapsed or Refractory Metastatic Non-Small Cell Lung CancerTerminatedNo Results AvailableNSCLCDrug: erlotinib and bortezomibhttps://ClinicalTrials.gov/show/NCT00283634
173622173622Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and IfosfamideCompletedNo Results AvailableSarcomaDrug: Aranesp (darbepoetin alfa)|Drug: Neulasta (pegfilgrastim)|Drug: Adriamycin|Drug: Ifosfamidehttps://ClinicalTrials.gov/show/NCT00283621
173623173623Pharmacogenetics of Anastrozole in Postmenopausal Women With Estrogen Receptor-Positive and/or Progesterone Receptor-Positive Stage I, Stage II, or Stage III Breast CancerCompletedNo Results AvailableBreast CancerGenetic: Single nucleotide polymorphism (SNP)|Other: high performance liquid chromatography|Other: measurements by DXA|Other: questionnaire administrationhttps://ClinicalTrials.gov/show/NCT00283608
173624173624Effect of Growth Hormone on Bone Metabolism in Anorexia NervosaCompletedHas ResultsAnorexia Nervosa|Osteopenia|Osteoporosis|Eating DisordersDrug: Recombinant Human Growth Hormone|Drug: Placebo for Recombinant Human Growth Hormonehttps://ClinicalTrials.gov/show/NCT00283595
173625173625Trial of Primary Prophylaxis With rhTPO Administered to Patients With High Risk Sarcoma Receiving Intensive ChemotherapyCompletedNo Results AvailableSarcomaDrug: rhTPOhttps://ClinicalTrials.gov/show/NCT00283582
173626173626Genetic Epidemiology of Adult Onset GliomaCompletedNo Results AvailableAdult-Onset GliomaOther: Mouth Swab, Toe Nail Clippings, Questionnaireshttps://ClinicalTrials.gov/show/NCT00283569
173627173627High Dose Camptothecin-11 (CPT-11) in Recurrent Unresectable Malignant GliomaCompletedNo Results AvailableMalignant GliomaDrug: Irinotecan (Camptosar, CPT-11)https://ClinicalTrials.gov/show/NCT00283556
173628173628Radiation With Concomitant and Then Sequential Temozolomide in Malignant GliomaActive, not recruitingNo Results AvailableNewly Diagnosed Supratentorial Malignant GliomaDrug: Gliadel Wafer|Drug: Temozolomide|Procedure: Limited field radiationhttps://ClinicalTrials.gov/show/NCT00283543
173629173629Tumor Phenotypes and Correlation to Clinical Outcomes in CancerTerminatedNo Results AvailableCancerProcedure: Tumor biopsyhttps://ClinicalTrials.gov/show/NCT00283530
173630173630A Registry of Treatment Adherence for Patients With SchizophreniaCompletedNo Results AvailableSchizophrenia|Psychotic DisordersDrug: antipsychoticshttps://ClinicalTrials.gov/show/NCT00283517
173631173631A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE TherapyCompletedNo Results AvailableAllergic AsthmaDrug: ANTI-IGE THERAPY (XOLAIR)https://ClinicalTrials.gov/show/NCT00283504
173632173632The Effect of Lactobacillus Cultures on Iron Bioavailability.CompletedNo Results AvailableLow Iron StoresBehavioral: Active Lactobacillus plantarum 299v|Dietary Supplement: Inactive Lactobacillus plantarum 299vhttps://ClinicalTrials.gov/show/NCT00283491
173633173633Iscar for Second Line Treatment of Advanced Non-Small Cell Lung CancerCompletedNo Results AvailableNon-Small Cell Lung CancerDrug: Iscar Quercus|Drug: Gemcitabinehttps://ClinicalTrials.gov/show/NCT00283478
173634173634A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing ChemotherapyCompletedNo Results AvailableAnemia|NeoplasmDrug: Epoetin alfahttps://ClinicalTrials.gov/show/NCT00283465
173635173635Keep Active MinnesotaCompletedNo Results AvailablePhysical Activity MaintenanceBehavioral: Phone counseling with written materialshttps://ClinicalTrials.gov/show/NCT00283452
173636173636A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With LymphomaCompletedHas ResultsChemotherapy-Induced Thrombocytopenia|Hodgkin's Lymphoma|Non-Hodgkin's Lymphoma|Cancer|Oncology|ThrombocytopeniaBiological: AMG 531https://ClinicalTrials.gov/show/NCT00283439
173637173637Efficacy and Safety Study of Soluble Beta-1,3/1,6-Glucan in Thermal BurnsTerminatedNo Results AvailableBurnsDrug: Soluble beta-1,3/1,6-glucanhttps://ClinicalTrials.gov/show/NCT00283426
173638173638Symbiot III: A Prospective Randomized Trial Evaluating the Symbiot Covered Stent System in Saphenous Vein GraftsCompletedNo Results AvailableSymptomatic Ischemic Saphenous Vein Graft DiseaseDevice: Covered Stent System|Device: Bare metal stenthttps://ClinicalTrials.gov/show/NCT00283413
173639173639Treatment of Subarachnoid Hemorrhage With Human AlbuminTerminatedHas ResultsSubarachnoid HemorrhageDrug: 25% human albuminhttps://ClinicalTrials.gov/show/NCT00283400
173640173640Efficacy of Betaine for Reduction of Urine Oxalate in Patients With Type 1 Primary HyperoxaluriaCompletedHas ResultsHyperoxaluriaDrug: Betaine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00283387

* Görseller ve İçerik tekif hakkına sahip olabilir